Skip to main content

Peer Review reports

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Original Submission
28 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Mar 2023 Author responded Author comments - Peng Chen
Resubmission - Version 3
29 Mar 2023 Submitted Manuscript version 3
28 May 2023 Reviewed Reviewer Report - K. Sreedhara Ranganath Pai
8 Aug 2023 Reviewed Reviewer Report
24 Oct 2023 Reviewed Reviewer Report
12 Nov 2023 Author responded Author comments - Peng Chen
Resubmission - Version 4
12 Nov 2023 Submitted Manuscript version 4
19 Nov 2023 Author responded Author comments - Peng Chen
Resubmission - Version 5
19 Nov 2023 Submitted Manuscript version 5
25 Nov 2023 Author responded Author comments - Peng Chen
Resubmission - Version 6
25 Nov 2023 Submitted Manuscript version 6
29 Nov 2023 Author responded Author comments - Peng Chen
Resubmission - Version 7
29 Nov 2023 Submitted Manuscript version 7
2 Dec 2023 Reviewed Reviewer Report
9 Dec 2023 Reviewed Reviewer Report
15 Dec 2023 Reviewed Reviewer Report - K. Sreedhara Ranganath Pai
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
27 Dec 2023 Editorially accepted
8 Jan 2024 Article published 10.1186/s12906-023-04332-x

You can find further information about peer review here.

Back to article page